BETHLEHEM, Pa., May 02, 2017 -- Furthering its efforts to enhancing patient, clinician and environmental safety, B. Braun Medical Inc. will debut ReadyFor800.com at The Oncology Nursing Society’s Annual Conference, May 4-7 in Denver, Colorado. The new online educational resource will focus on the awareness and implementation of the new hazardous drug safety standard, USP <800>.
“These medications can save the lives of patients, but they also pose risk to our healthcare professionals,” said Tom Sutton, Vice President of Vascular Access Systems at B. Braun. “As one of the leading suppliers of Closed System Transfer Devices (CSTDs) in the United States, B. Braun takes responsibility to help nurses and other healthcare workers proactively protect not only their patients, but also themselves and their coworkers.”
ReadyFor800.com details the risks for healthcare personnel and introduces implementation plans and protocols to ensure the best protection possible from hazardous drug exposure. Supported by expert insight, experience, and recommendations, and told from the pharmacy, nursing and management perspectives, ReadyFor800.com is a comprehensive tool for educating staff and colleagues. It provides a blue print to help implement USP <800> in hospital or outpatient facilities.
At ONS 2017, attendees can visit B. Braun booth #925 to experience ReadyFor800.com. Attendees can gain an understanding of the risks involved in the compounding and administering of hazardous drugs, and discuss the steps required for USP <800> compliance with ONS Connect contributing editor Seth Eisenberg, RN, ASN, OCN®, BMTCN™.
About USP <800>
USP <800> was published on February 1, 2016 with an implementation date of July 1, 2018. The chapter describes practice and quality standards for the handling of hazardous drugs, including transport, storage, preparation, and administration, in healthcare settings to help promote patient safety, worker safety, and environmental protection. USP <800> applies to all healthcare personnel – such as pharmacists, technicians, nurses, physicians, physician assistants, home healthcare workers, veterinarians, and veterinary technicians – as well as all facilities associated with the handling of hazardous drugs.
About B. Braun
B. Braun Medical Inc., a market leader in Closed System Drug Transfer Devices, develops, manufactures, and markets innovative medical products and services to the healthcare industry. The company is committed to eliminating preventable treatment errors and enhancing patient, clinician and environmental safety. The OnGuard® CSTD from B. Braun is designed to help protect healthcare workers within the pharmacy and specifically during nursing administration of hazardous drugs. OnGuard meets the NIOSH, ASHP, and ONS definitions of a CSTD, along with all proposed USP <800> requirements.
To learn more about B. Braun Medical or OnGuard CSTD, visit www.BBraunUSA.com.
Contact: Jason Ford B. Braun Medical Inc. 610.997.4722 [email protected]


Robinhood Q1 Earnings Miss Expectations, Stock Drops After Hours
Google Secures Pentagon AI Deal for Classified Projects
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
China’s Ultra-Cheap EV Boom: Why Electric Cars Cost Far Less Than in the U.S.
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Seagate Stock Surges After Strong Q3 Earnings Beat and Bullish Outlook
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
TSMC Exits Arm Holdings with $231 Million Share Sale Amid Strategic Portfolio Shift
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Pershing Square Raises $5 Billion in Landmark U.S. IPO and Share Placement
Why Paycom Was Named a 2026 Platinum Employer on the Where You Work Matters List
U.S. Demand for Alternative Satellite Providers Remains Strong Amid SpaceX Regulatory Push
T-Mobile Beats Q1 Earnings Expectations on Strong Postpaid Growth 



